Death due to recurrent thromboembolism among younger healthier individuals hospitalized for idiopathic pulmonary embolism

Thrombosis and Haemostasis

Volumn 99, Issue 4, 2008, Pages 683-690

  White, Richard H ^a,b   Zhou, Hong ^a   Murin, Susan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PSSB   (United States)

Author keywords

Administrative data; Epidemiology; PE; Thromboembolism; Venous thrombosis

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; DEATH; FATALITY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECURRENT DISEASE; REGISTER; RETROSPECTIVE STUDY; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; ANTICOAGULANTS; CALIFORNIA; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RECURRENCE; RETROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM;

EID: 43749118513     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-09-0557     Document Type: Article

References (36)

1. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107 (23 Suppl 1): I22-30.
2. Aujesky D, Smith KJ, Roberts MS. Oral anticoagulation strategies after a first idiopathic venous thromboembolic event. Am J Med 2005; 118: 625-635.
3. Kearon C. Long-term management of patients after venous thromboembolism. Circulation 2004; 110 (9 Suppl 1): I10-18.
4. Keeling D. Duration of anticoagulation: decision making based on absolute risk. Blood Rev 2006; 20: 173-178.
5. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117: 19-25.
6. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389.
7. Piccioli A, Prandoni P, Goldhaber SZ. Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a tertiary-care hospital: the Brigham and Women's Hospital DVT registry. Am Heart J 1996; 132: 1010-1014.
8. Douketis JD, Kearon C, Bates S, et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. J Am Med Assoc 1998; 279: 458-462.
9. Janke RM, McGovern PG, Folsom AR. Mortality, hospital discharges, and case fatality for pulmonary embolism in the Twin Cities: 1980-1995. J Clin Epidemiol 2000; 53: 103-109.
10. Stein PD, Kayali F, Olson RE. Estimated case fatality rate of pulmonary embolism, 1979 to 1998. Am J Cardiol 2004; 93: 1197-1199.
11. Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000; 160: 761-768.
12. Ageno W, Prandoni P, Romualdi E, et al. The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost 2006; 4: 1914-1918.
13. Douketis JD, Foster GA, Crowther MA, et al. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med 2000; 160: 3431-3436.
14. Iles S, Dalen JE. Clot burden and comorbidity in natural history of untreated pulmonary thromboembolism: Autopsy data in the trial by Barritt and Jordan. Chest 2003; 124: 1178-1179.
15. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107 (23 Suppl 1): I4-8.
16. Douketis JD, Gu CS, Schulman S, et al. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med 2007; 147: 766-774.
17. White RH, Romano PS, Zhou H, et al. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998; 158: 1525-1531.
18. White RH, Zhou H, Murin S, et al. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93: 298-305.
19. White RH, Dager WE, Zhou H, et al. Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost 2006; 96: 267-273.
20. Healthcare Costs and Utilization Project. Comorbidity Software, Version 3.1. 2005 Fiscal Year 2006. Cited April 3, 2006; Available from: http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp
21. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27.
22. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004; 57: 131-141.
23. Alcalay A, Wun T, Khatri V, et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 2006; 24: 1112-1118.
24. Stukenborg GJP, Wagner DPP, Connors AFJMD. Comparison of the performance of two comorbidity measures, with and without information from prior hospitalizations. Med Care 2001; 39: 727-739.
25. Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care 2004; 42: 355-360.
26. White RH, Beyth RJ, Zhou H, et al. Major bleeding after hospitalization for deep-venous thrombosis. Am J Med 1999; 107: 414-424.
27. Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health, 2007. Cited; Version 2.2: Available from: www.OpenEpi.com.
28. Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002; 88: 407-414.
29. Tapson VF, Humbert M. Incidence and prevalence of chronic thromboembolic pulmonary hypertension: From acute to chronic pulmonary embolism. Proc Am Thorac Soc 2006; 3: 564-567.
30. Pengo V, Lensing AWA, Prins MH, et al. Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism. N Engl J Med 2004; 350: 2257-2264.
31. Mayo JR, Remy-Jardin M, Muller NL, et al. Pulmonary embolism: prospective comparison of spiral CT with ventilation-perfusion scintigraphy. Radiology 1997; 205: 447-452.
32. Kraaijenhagen RA, Lensing AWA, Wallis JW, et al. Diagnostic management of venous thromboembolism. Bailliere's Clin Haematol 1998; 11: 541-586.
33. White TM, Kellis DS, Hightower SF. Conformance of clinical practice to established recommendations for the diagnosis and treatment of venous thromboembolic disease: Robin revisited. Am J Med Qual 1994; 9: 153-157.
34. Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica 2007; 92: 199-205.
35. Agnelli G, Prandoni P, Becattini C, et al. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med 2003; 139: 19-25.
36. Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 1995; 332: 1661-1665.